Shinchi Y - Search Results

1

Comparison of survivals between sublobar resection and lobar resection for patients with clinical stage I non-small cell lung cancer and interstitial lung disease: a propensity score matching analysis.

Matsushima R, Fujino K, Motooka Y, Yamada H, Shirakami C, Shinchi Y, Osumi H, Yamada T, Yoshimoto K, Ikeda K, Kubota I, Suzuki M. Matsushima R, et al. Among authors: shinchi y. Thorac Cancer. 2024 Oct;15(30):2166-2174. doi: 10.1111/1759-7714.15418. Epub 2024 Sep 9. Thorac Cancer. 2024. PMID: 39250336 Free PMC article.

2

NUF2 Expression in Cancer Tissues and Lymph Nodes Suggests Post-Surgery Recurrence of Non-Small Cell Lung Cancer.

Shirakami C, Ikeda K, Hinokuma H, Nishi W, Shinchi Y, Matsubara E, Osumi H, Fujino K, Suzuki M. Shirakami C, et al. Among authors: shinchi y. Diagnostics (Basel). 2024 Feb 21;14(5):471. doi: 10.3390/diagnostics14050471. Diagnostics (Basel). 2024. PMID: 38472943 Free PMC article.

3

IL-32 production from lung adenocarcinoma cells is potentially involved in immunosuppressive microenvironment.

Zhao S, Li L, Komohara Y, Matsubara E, Shinchi Y, Adawy A, Yano H, Pan C, Fujiwara Y, Ikeda K, Suzu S, Hibi T, Suzuki M. Zhao S, et al. Among authors: shinchi y. Med Mol Morphol. 2024 Jun;57(2):91-100. doi: 10.1007/s00795-023-00378-5. Epub 2024 Feb 6. Med Mol Morphol. 2024. PMID: 38316697

4

PD-L2 overexpression on tumor-associated macrophages is one of the predictors for better prognosis in lung adenocarcinoma.

Matsubara E, Shinchi Y, Komohara Y, Yano H, Pan C, Fujiwara Y, Ikeda K, Suzuki M. Matsubara E, et al. Among authors: shinchi y. Med Mol Morphol. 2023 Dec;56(4):250-256. doi: 10.1007/s00795-023-00361-0. Epub 2023 Jul 4. Med Mol Morphol. 2023. PMID: 37402054

5

The Significance of SPP1 in Lung Cancers and Its Impact as a Marker for Protumor Tumor-Associated Macrophages.

Matsubara E, Yano H, Pan C, Komohara Y, Fujiwara Y, Zhao S, Shinchi Y, Kurotaki D, Suzuki M. Matsubara E, et al. Among authors: shinchi y. Cancers (Basel). 2023 Apr 12;15(8):2250. doi: 10.3390/cancers15082250. Cancers (Basel). 2023. PMID: 37190178 Free PMC article. Review.

6

A Potential Novel Treatment for Chronic Cough in Long COVID Patients: Clearance of Epipharyngeal Residual SARS-CoV-2 Spike RNA by Epipharyngeal Abrasive Therapy.

Nishi K, Yoshimoto S, Tanaka T, Kimura S, Shinchi Y, Yamano T. Nishi K, et al. Among authors: shinchi y. Cureus. 2023 Jan 5;15(1):e33421. doi: 10.7759/cureus.33421. eCollection 2023 Jan. Cureus. 2023. PMID: 36618501 Free PMC article.

7

SPP1 Derived from Macrophages Is Associated with a Worse Clinical Course and Chemo-Resistance in Lung Adenocarcinoma.

Matsubara E, Komohara Y, Esumi S, Shinchi Y, Ishizuka S, Mito R, Pan C, Yano H, Kobayashi D, Fujiwara Y, Ikeda K, Sakagami T, Suzuki M. Matsubara E, et al. Among authors: shinchi y. Cancers (Basel). 2022 Sep 8;14(18):4374. doi: 10.3390/cancers14184374. Cancers (Basel). 2022. PMID: 36139536 Free PMC article.

8

Classification of PD-L1 expression in various cancers and macrophages based on immunohistocytological analysis.

Saito Y, Fujiwara Y, Shinchi Y, Mito R, Miura Y, Yamaguchi T, Ikeda K, Urakami S, Nakashima Y, Sakagami T, Suzuki M, Tabata Y, Komohara Y. Saito Y, et al. Among authors: shinchi y. Cancer Sci. 2022 Sep;113(9):3255-3266. doi: 10.1111/cas.15442. Epub 2022 Jun 15. Cancer Sci. 2022. PMID: 35633190 Free PMC article.

9

The expression of PD-1 ligand 1 on macrophages and its clinical impacts and mechanisms in lung adenocarcinoma.

Shinchi Y, Ishizuka S, Komohara Y, Matsubara E, Mito R, Pan C, Yoshii D, Yonemitsu K, Fujiwara Y, Ikeda K, Tamada K, Sakagami T, Suzuki M. Shinchi Y, et al. Cancer Immunol Immunother. 2022 Nov;71(11):2645-2661. doi: 10.1007/s00262-022-03187-4. Epub 2022 Mar 29. Cancer Immunol Immunother. 2022. PMID: 35352168 Free PMC article.

10

Soluble Factors Involved in Cancer Cell-Macrophage Interaction Promote Breast Cancer Growth.

Yonemitsu K, Miyasato Y, Shiota T, Shinchi Y, Fujiwara Y, Hosaka S, Yamamoto Y, Komohara Y. Yonemitsu K, et al. Among authors: shinchi y. Anticancer Res. 2021 Sep;41(9):4249-4258. doi: 10.21873/anticanres.15229. Anticancer Res. 2021. PMID: 34475044

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters